Germany`s Merck gets EU backing for oral MS drug
(Reuters Health)

FRANKFURT (Reuters) - Germany`s Merck KGaA has won a key recommendation to become a late entrant to the market for oral multiple sclerosis (MS) drugs in Europe, six years after its first attempt to launch the cladribine pill failed.